Pictet Asset Management (UK)’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$5.75M Buy
101,459
+96,459
+1,929% +$3.56M 0.01% 814
2021
Q1
$210K Buy
5,000
+200
+4% +$11.4K ﹤0.01% 1661
2020
Q4
$337K Buy
+4,800
New +$197K ﹤0.01% 1331
2019
Q1
Sell
-144,588
Closed -$3.29K 1003
2018
Q4
$3.29K Sell
144,588
-2,765
-2% -$75.2K 0.01% 746
2018
Q3
$4.69M Buy
147,353
+41,777
+40% +$1.35M 0.01% 751
2018
Q2
$3.78M Buy
+105,576
New +$3.74M 0.01% 718

Other funds holding EDIT

Pictet Asset Management (UK)'s EDIT Position: Q2 2021 in Review

Pictet Asset Management (UK) increased its Editas Medicine (EDIT) stake by 1,929% in Q2 2021, buying an estimated $3.56M and bringing the position to 101,459 shares worth $5.75M. The position accounts for 0.01% of the portfolio, ranked #814.

Pictet Asset Management (UK) first reported a position in EDIT in Q2 2018 and has held it in 6 quarters since. 313 funds tracked by Wall St. Rank hold EDIT as of Q2 2021.

  • Pictet Asset Management (UK) held 101,459 shares of Editas Medicine worth $5.75M as of Q2 2021.
  • Pictet Asset Management (UK) bought 96,459 Editas Medicine shares in Q2 2021, an estimated $3.56M.
  • Editas Medicine made up 0.01% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #814 holding.
  • Pictet Asset Management (UK) first reported a position in Editas Medicine in Q2 2018 and has held it in 6 quarters since.
  • 313 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.